What was Cipla’s net profit in Q3 FY25–26?
- Answer Field
-
Cipla reported a consolidated net profit (PAT) of ₹674.25 crore in Q3 FY25–26.
Cipla reported consolidated revenue from operations of ₹7,074.48 crore in Q3 FY25–26, broadly flat YoY. Net profit stood at ₹674.25 crore, reflecting a decline compared to the year-ago quarter, impacted by exceptional items, as per its exchange filing.
Cipla announced its unaudited consolidated financial results on 23 January 2026 for the quarter ended December 31, 2025 (Q3 FY25–26). The company reported stable revenue performance, while profitability declined on a year-on-year basis due to lower operating profit and an exceptional loss during the quarter.
On a consolidated basis, revenue from operations stood at ₹7,074.48 crore, while net profit for the quarter came in at ₹674.25 crore.
Cipla Q3 Results FY25–26 Date & Announcement
Cipla declared its Q3 FY25–26 financial results on 23 January 2026, covering the consolidated performance for the quarter ended December 31, 2025, as disclosed through its stock exchange filing.
All figures in ₹ crore | Consolidated | Unaudited
Particulars | Q3 FY25–26 | Q2 FY25–26 | Q3 FY24–25 | YoY % | QoQ % |
Revenue from the Sale of Products | 6,962.97 | 7,447.42 | 6,961.60 | 0.0% | (6.5%) |
Other Operating Revenue | 111.51 | 142.02 | 111.37 | 0.1% | (21.5%) |
Total Revenue from Operations | 7,074.48 | 7,589.44 | 7,072.97 | 0.0% | (6.8%) |
Other Income | 206.34 | 268.95 | 221.61 | (6.9%) | (23.3%) |
Total Income | 7,280.82 | 7,858.39 | 7,294.58 | (0.2%) | (7.3%) |
Total Expenses | 6,111.80 | 6,004.86 | 5,378.49 | 13.6% | 1.8% |
Profit Before Exceptional Items & Tax | 1,169.02 | 1,853.53 | 1,916.09 | (39.0%) | (36.9%) |
Exceptional Item (Loss) | (275.91) | — | — | — | — |
Profit Before Tax (PBT) | 893.11 | 1,853.53 | 1,916.09 | (53.4%) | (51.8%) |
Tax Expense (Net) | 218.55 | 500.46 | 332.37 | (34.2%) | (56.3%) |
Net Profit (PAT) | 674.25 | 1,353.37 | 1,574.59 | (57.2%) | (50.2%) |
EPS – Basic (₹) | 8.37 | 16.73 | 19.45 | (57.0%) | (50.0%) |
EPS – Diluted (₹) | 8.36 | 16.72 | 19.43 | (57.0%) | (50.0%) |
All figures in ₹ crore | Consolidated | Unaudited
Particulars | Q3 FY25–26 | Q2 FY25–26 | QoQ Change |
Total Revenue from Operations | 7,074.48 | 7,589.44 | (6.8%) |
Other Income | 206.34 | 268.95 | (23.3%) |
Total Income | 7,280.82 | 7,858.39 | (7.3%) |
Total Expenses | 6,111.80 | 6,004.86 | 1.8% |
Profit Before Tax (PBT) | 893.11 | 1,853.53 | (51.8%) |
Tax Expense (Net) | 218.55 | 500.46 | (56.3%) |
Net Profit (PAT) | 674.25 | 1,353.37 | (50.2%) |
EPS – Basic (₹) | 8.37 | 16.73 | (50.0%) |
EPS – Diluted (₹) | 8.36 | 16.72 | (50.0%) |
On a quarter-on-quarter basis, Cipla reported a decline in profitability as revenue moderated sequentially while costs remained elevated, resulting in lower earnings during the quarter.
Figures are consolidated, unaudited, and represent Q3 FY25–26 only.
Segment | Q3 FY25–26 Revenue | Q2 FY25–26 Revenue | Q3 FY24–25 Revenue |
Pharmaceuticals | 6,746.40 | 7,291.43 | 6,777.84 |
New Ventures | 381.48 | 350.68 | 341.30 |
Total Segment Revenue | 7,127.88 | 7,642.11 | 7,119.14 |
Less: Inter-segment Revenue | (53.40) | (52.67) | (46.17) |
Total Revenue from Operations | 7,074.48 | 7,589.44 | 7,072.97 |
Segment | Q3 FY25–26 Segment Result | Q2 FY25–26 Segment Result | Q3 FY24–25 Segment Result |
Pharmaceuticals | 1,122.26 | 1,825.49 | 1,888.86 |
New Ventures | 60.79 | 41.22 | 41.87 |
Total Segment Result | 1,183.05 | 1,866.71 | 1,930.73 |
Less: Finance Costs | 14.03 | 13.18 | 14.64 |
Profit Before Exceptional Items & Tax | 1,169.02 | 1,853.53 | 1,916.09 |
Less: Exceptional Item (Loss) | 275.91 | — | — |
Profit Before Tax (PBT) | 893.11 | 1,853.53 | 1,916.09 |
Pharmaceuticals remained the largest contributor to consolidated revenue and profitability during the quarter, while New Ventures contributed a smaller share of revenue and profit.
Cipla released its quarterly results during market hours. As of 2 PM IST on 23 January 2026, Cipla’s share price is trading at ₹1311.55 on the NSE, down by 4.37%.
Cipla’s Q3 FY25–26 results indicate declining operating revenue but a decline in net profit on both a year-on-year and quarter-on-quarter basis. The performance reflects pressure on profitability during the quarter, along with the impact of an exceptional loss.
For more quarterly result updates, visit Bajaj Broking’s Quarterly Results Calendar.
Share this article:
No result found
Cipla reported a consolidated net profit (PAT) of ₹674.25 crore in Q3 FY25–26.
Revenue from operations stood at ₹7,074.48 crore during the quarter.
Basic EPS stood at ₹8.37, while diluted EPS was ₹8.36.
Net profit declined 57.2% YoY, while revenue from operations remained broadly flat YoY.
Net profit declined 50.2% QoQ, as profitability weakened sequentially during the quarter.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading